Atlas Trials

Biomarkers of Synaptic Damage in Multiple Sclerosis

Clinical trial NCT03217396 · RECRUITING

Trial details

NCT number
NCT03217396
Sponsor
Neuromed IRCCS
Status
RECRUITING
Study type
OBSERVATIONAL
Multiple SclerosisParkinson DiseaseAmyotrophic Lateral SclerosisAlzheimer Disease
Start date
2017-11-22
Primary completion
2026-09-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.